secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001104659-24-068701
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio schedules investor webcast for June 11 to discuss Buntanetap progress
--------------------------------------------------------------------------------

- Webcast scheduled for June 11, 2024 at 4:30pm ET; registration via Zoom link provided.
- Topics include recent Buntanetap developments, upcoming clinical trial plans, and company progress.
- Buntanetap is a late-stage drug candidate for Alzheimer's and Parkinson's diseases.
- No specific data or results disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924068701/0001104659-24-068701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924068701/tm2416510d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer